Patrick Hope
- Democratic
- Delegate
- District 1
Primary
Naloxone or other opioid antagonists; possession and administration by state agencies. Requires state agencies to possess naloxone or other opioid antagonists used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose and permits employees of any state agency to possess and administer naloxone or other opioid antagonists. The bill also directs the Department of Health to post on its website informational resources relating to the use of naloxone and other opioid antagonists for opioid overdose reversal and prevention in public places. Finally, the bill directs the Department of Health to develop a plan for the procurement and distribution of naloxone or other opioid antagonists to each state agency and for the possession of naloxone or other opioid antagonists by each state agency and to report its progress in developing such plan to the Governor and the Chairmen of the House Committee on Health and Human Services and the Senate Committee on Education and Health by November 1, 2024.
Naloxone or other opioid antagonists; possession and administration by state agencies. Requires state agencies to possess naloxone or other opioid antagonists used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose and permits employees of any state agency to possess and administer naloxone or other opioid antagonists.
Naloxone or other opioid antagonists; possessionby state agencies; guidelines for private employers. Requiresthe Department of General Services, in consultation with the Departmentof Health, to promulgate regulations for the possession and the administrationby state employees of naloxone or other opioid antagonists used foroverdose reversal to a person who is believed to be experiencingor about to experience a life-threatening opioid overdose and requireseach state agency to possess such naloxone or other opioid antagonistused for overdose reversal in accordance with such regulations. Thebill also requires the Department of Health, in consultation withthe Safety and Health Codes Board, to issue guidelines for the possession and administration of naloxone or other opioid antagonists by privateemployers used for overdose reversal to a person who is believedto be experiencing or about to experience a life-threatening opioidoverdose.
Acts of Assembly Chapter text (CHAP0440)
Approved by Governor-Chapter 440 (effective 7/1/24)
Governor's Action Deadline 11:59 p.m., April 8, 2024
Enrolled Bill communicated to Governor on March 27, 2024
Impact statement from DPB (HB342ER)
Signed by Speaker
Bill text as passed House and Senate (HB342ER)
Signed by President
Enrolled
Conference substitute printed 24109115D-H2
Impact statement from DPB (HB342H2)
VOTE: Adoption (95-Y 0-N)
Conference report agreed to by House (95-Y 0-N)
Conference report agreed to by Senate (40-Y 0-N)
Amended by conference committee
VOTE: REJECTED (0-Y 99-N)
Delegates: Hope, Shin, Higgins
Conferees appointed by House
Senators: Favola, Aird, Head
Conferees appointed by Senate
House acceded to request
Senate requested conference committee
Senate insisted on substitute (40-Y 0-N)
Senate substitute rejected by House 24108846D-S1 (0-Y 99-N)
Committee substitute agreed to 24108846D-S1
Read third time
Reading of substitute waived
Engrossed by Senate - committee substitute HB342S1
Passed Senate with substitute (40-Y 0-N)
Constitutional reading dispensed (39-Y 0-N)
Impact statement from DPB (HB342S1)
Committee substitute printed 24108846D-S1
Reported from Finance and Appropriations with substitute (15-Y 0-N)
Reported from Education and Health (15-Y 0-N)
Rereferred to Finance and Appropriations
Assigned Education and Health Sub: Health Professions
Referred to Committee on Education and Health
Constitutional reading dispensed
VOTE: Block Vote Passage (100-Y 0-N)
Read third time and passed House BLOCK VOTE (100-Y 0-N)
Impact statement from DPB (HB342H1)
Engrossed by House - committee substitute HB342H1
Committee substitute agreed to 24106801D-H1
Read second time
Read first time
Committee substitute printed 24106801D-H1
Reported from Health and Human Services with substitute (22-Y 0-N)
House subcommittee amendments and substitutes offered
Subcommittee recommends referring to Committee on Appropriations
Subcommittee recommends reporting with substitute (8-Y 0-N)
Impact statement from DPB (HB342)
Assigned sub: Health
Prefiled and ordered printed; offered 01/10/24 24100674D
Referred to Committee on Health and Human Services
| Bill Text Versions | Format |
|---|---|
| Prefiled and ordered printed; offered 01/10/24 24100674D | PDF HTML |
| Committee substitute printed 24106801D-H1 | PDF HTML |
| Committee substitute printed 24108846D-S1 | PDF HTML |
| Conference substitute printed 24109115D-H2 | PDF HTML |
| HB342ER | PDF HTML |
| CHAP0440 | PDF HTML |
| Document | Format |
|---|---|
| Fiscal Impact Statement: HB342FER122.PDF | |
| Fiscal Impact Statement: HB342FH2122.PDF | |
| Fiscal Impact Statement: HB342FS1122.PDF | |
| Fiscal Impact Statement: HB342FH1122.PDF | |
| Fiscal Impact Statement: HB342F122.PDF | |
| Amendment: HB342AC | HTML |
Data on Open States is updated periodically throughout the day from the official website of the Virginia General Assembly.
If you notice any inconsistencies with these official sources, feel free to file an issue.